02511.HK
HighTide Therapeutics Inc
HKSE · Healthcare · Biotechnology · CN
HKD 3.30
+5.60%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.62x
- Price / sales
- —
- Price / cash flow
- -32.40x
Enterprise value
- Enterprise value
- HKD 1.5B
- EV / sales
- —
- EV / EBITDA
- -7.28x
- EV / EBIT
- -7.25x
- Market cap
- HKD 1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026